Hearing News Watch

LYNGE, DENMARK — WSA announced that Chief Financial Officer Marianne Wiinholt will step down from her role on August 31, 2026, after four years as CFO and a member of the company’s Executive Committee. According to the company, Wiinholt made the decision to leave at her own request to pursue a portfolio of board and advisory roles. She will remain

A new book by veteran audiologist Garry G. Gordon, MS, examines how hearing healthcare professionals may expand their services beyond traditional clinical practice through industrial hearing conservation, recreational hearing protection, tinnitus management, and emerging hearing technologies. Recreational & Industrial Audiology: The Next Profitable Frontier outlines potential growth areas as the hearing healthcare landscape continues to evolve. Drawing on decades of

EDEN PRAIRIE, MINNESOTA — Starkey has been named a 2026 Star Tribune Top Workplace, marking the fifth consecutive year the company has earned the distinction. The award is based entirely on employee feedback gathered through a confidential engagement survey that measures workplace culture, leadership, communication, and employee experience. The recognition reflects Starkey’s ongoing commitment to fostering a workplace where employees are

Hearing healthcare is evolving rapidly. While advances in technology continue to transform the profession, there is also a growing emphasis on patient-centered care that extends beyond the audiogram to communication, participation, and quality of life. To better understand where the profession stands today, HHTM is inviting hearing care professionals to participate in the Current State of Hearing Care Survey. The

TÜBINGEN, GERMANY — Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, today announced positive top-line efficacy results from its completed Phase 2a PROHEAR study. ACOU085 (INN: Bimokalner) is a proprietary small-molecule therapy that has demonstrated efficacy across multiple preclinical models of hearing loss, including drug-induced ototoxicity. The exploratory, placebo-controlled, split-body Phase 2a

IOWA CITY, IA — The University of Iowa has announced the upcoming 33rd Annual Management of the Tinnitus & Hyperacusis Patient International Conference, scheduled for August 13–14, 2026. The event will be offered in a hybrid format, with in-person sessions held at the Wendell Johnson Speech & Hearing Center, as well as a remote attendance option. The long-running conference is

Hearing Health & Technology Matters (HHTM) is now accepting submissions for the 7th Annual Hearing Technology Innovator Awards™, an international awards program recognizing technological innovation and achievement across the hearing industry. Now entering its seventh year, the awards program honors the products, services, and technologies that are pushing the boundaries of hearing healthcare through innovation, accessibility, and improved patient care.

MONTPELLIER, FRANCE — Sensorion announced that it has selected SENS-601, its gene therapy candidate for GJB2-related hearing loss, as the company’s lead gene therapy program after achieving several key regulatory milestones. The company has filed Clinical Trial Applications in Canada and France, with additional submissions planned in the United States and Australia by the end of 2026. The announcement also

STRUER, DENMARK — Sound Hub Denmark will host SOUND Pitch & Buzz #7 on Thursday, June 11, bringing together entrepreneurs, investors, and industry leaders to showcase the latest innovations emerging from the world’s only dedicated SoundTech Accelerator. The annual event marks the culmination of the accelerator’s six-month program, with eight international startups presenting technologies spanning hearing accessibility, healthcare, artificial intelligence,

WS Audiology (WSA) has acquired IntoEars & Oogvoororen, a hearing care provider with 28 locations across the Netherlands and Belgium, further expanding the company’s direct retail presence in Europe. The transaction was completed through WSA Retail, the company’s retail division. WSA is one of the world’s largest hearing healthcare companies and the parent company of hearing technology brands including Signia,